Muthu Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 3.00 M
- Revenue Growth 97.08%
- Profit Growth 121.30%
- Ebitda 1.16%
- Net Worth 1.21%
- Total Assets 32.95%
About Muthu Pharmaceutical
Muthu Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 December 2016 (Eight years and two months 15 days old ). Its registered office is in Virudhunagar, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹3.00 M.
Subbiah Muthukumar, Muthukumar Dhanalakshmi, Solaiappan Arunadevi, and One other member serve as directors at the Company.
Company Details
- Location
Virudhunagar, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TN2016PTC113693
- Company No.
113693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Dec 2016
- Date of AGM
19 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Muthu Pharmaceutical?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muthukumar Dhanalakshmi  | Managing Director | 13-Dec-2016 | Current |
| Solaiappan Arunadevi | Managing Director | 13-Dec-2016 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subbiah Muthukumar | Director | 13-Dec-2016 | Current |
| Mariappan Solaiappan | Director | 13-Dec-2016 | Current |
Financial Performance of Muthu Pharmaceutical.
Muthu Pharmaceutical Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 97.08% increase. The company also saw a substantial improvement in profitability, with a 121.3% increase in profit. The company's net worth moved up by a moderate rise of 1.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Muthu Pharmaceutical?
Unlock access to Muthu Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2020 | The South Indian Bank Limited | ₹0.50 M | Open |
| 20 Nov 2017 | The South Indian Bank Limited | ₹2.50 M | Open |
How Many Employees Work at Muthu Pharmaceutical?
Unlock and access historical data on people associated with Muthu Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Muthu Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Muthu Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.